Spectrophotometric Quantitation of Polysorbate in Protein Samples

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for determining the concentration of polysorbate in protein samples and drug-to-antibody ratios in antibody-drug conjugates are cumbersome, prone to errors, and require complex sample preparation due to overlapping absorbance spectra and binding issues, lacking direct and efficient measurement techniques.

Innovation Solution

The method employs spectrophotometric techniques to factor out overlapping signals by using the ratio of slopes from absorbance versus path length plots at different wavelengths, allowing for the direct measurement of polysorbate concentration in protein samples and drug-to-antibody ratios in ADCs without purification or dilution, using variable path-length spectrophotometry and slope spectroscopy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional spectrophotometric methods are used to measure polysorbate concentration, then measurement can be performed, but overlapping absorbance spectra cause measurement precision to deteriorate

Engineering Contradiction:
Improvepolysorbate concentration measurement precisionVSAvoidoverlapping absorbance spectra
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent segments the overlapping absorbance spectrum into multiple discrete wavelength measurements (at least two different wavelengths). By measuring absorbance at multiple wavelengths and solving the system of equations, the method isolates the polysorbate contribution from other components in the mixture, thereby resolving the measurement precision issue caused by spectral overlap.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent transitions from single-wavelength measurement to multi-wavelength measurement, adding a dimensional aspect to the measurement process. By incorporating wavelength as an additional measurement dimension and using mathematical resolution of overlapping spectra, the method achieves precise polysorbate quantification despite absorbance overlap.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If sample preparation steps (separation, filtration, dilution) are performed to improve measurement accuracy, then measurement precision improves, but time consumption and process complexity increase

Engineering Contradiction:
Improvepolysorbate concentration measurement precisionVSAvoidsample preparation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent enables the measurement system to handle complex mixtures directly without requiring external sample preparation interventions. The multi-wavelength spectrophotometric method with mathematical resolution allows the instrument to self-compensate for interfering substances, eliminating the need for manual separation, filtration, or dilution steps.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent extracts the polysorbate concentration information from the complex mixture by using multi-wavelength measurements and mathematical resolution. Instead of physically separating polysorbate from other components, the method extracts the specific spectral contribution of polysorbate through computational analysis of absorbance data at multiple wavelengths.

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If conventional methods are used to determine drug-to-antibody ratios, then measurement can be performed, but overlapping absorbance spectra and binding issues cause reliability to deteriorate

Engineering Contradiction:
Improvedrug-to-antibody ratio determination reliabilityVSAvoidoverlapping absorbance spectra and binding issues
Core Design Contradiction:
ReliabilityVSDifficulty of detecting and measuring

Solution Approach 1:

The patent segments the absorbance signal into distinct contributions from drug, antibody, and their conjugate by measuring at multiple wavelengths. The mathematical resolution process separates these overlapping signals, allowing reliable determination of drug-to-antibody ratios without interference from spectral overlap or binding-related measurement artifacts.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses more wavelength measurements than the minimum required, providing excess measurement data that enhances the reliability of the drug-to-antibody ratio determination. This excessive measurement approach allows for better statistical analysis and more robust resolution of overlapping spectra.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables accurate and efficient quantitation of polysorbate concentrations and drug-to-antibody ratios in complex mixtures, reducing errors and time consumption, and can be applied to solutions with multiple overlapping wavelengths, providing a direct and simplified measurement method.

Implementation Method 1

collecting a set of optical density versus wavelength spectra at two or more path lengths of a buffer of a solution

Methodology Applied
Scientific EffectAbsorbance spectroscopy: Absorption Spectroscopy

Implementation Method 2

using the ratio of slopes from absorbance versus path length plots at different wavelengths, allowing for the direct measurement of polysorbate concentration

Methodology Applied
Scientific EffectBeer-Lambert law: Absorption Spectroscopy

Data Source

PatentUS9404851B2Method for quantitatively measuring the concentration of a compound of unknown concentration in solution
Publication Date: 2016.08.02 REPLIGEN CORP
  • US9404851B2 patent drawing
  • US9404851B2 patent drawing
  • US9404851B2 patent drawing

AI summary

The present invention relates to methods of spectrophotometric determination of the presence of particular substances in a complex mixture of compounds. This invention relates to methods for determining the concentration of various components of complex biological samples including the determination of the concentration of polyoxyethylene containing compounds including polysorbate in protein containing samples as well as determining the ratio of drug to antibody ratios in antibody-drug conjugate solutions.